3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
3
Pancreatic Neoplasms
2
Glioblastoma
2
Smoking Cessation
1
Quality of Life
1
Patient Compliance
1
Overweight
1
Obesity
1
Motor Activity
1
Melanoma
1
Lung Neoplasms
1
Inflammation
1
Glioma
1
GastroEsophageal Cancer
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Advanced Malignant Solid Neoplasm
1
Interventions
Gemcitabine
29
pembrolizumab
21
Cisplatin
20
Specimen Handling
17
Magnetic Resonance Spectroscopy
17
enfortumab vedotin
10
Mitomycin
10
durvalumab
9
Cystoscopy
9
avelumab
8
Nivolumab
8
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
6
atezolizumab
5
Transurethral Resection of Bladder
5
Radiotherapy
5
Mitozytrex
5
Docetaxel
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Platinum
4
Immunoglobulin G
4
Disulfides
4
1,2-diaminocyclohexaneplatinum II citrate
4
disitamab vedotin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Diet Therapy
×
90 days
×
Clear all
No trials found.